IMVT
NASDAQStockImmunovant, Inc.
$24.39-0.60 (-2.42%)
52-Week Range
$13.31
$27.75
Key Stats
Market Cap
5.0B
P/E Ratio
—
Dividend Yield
—
Beta
0.63
Volume
552.3K
Avg Volume
1.1M
Performance
1M
-2.54%
3M
-3.88%
6M
+60.91%
YTD
-3.55%
1Y
+28.02%
3Y
+62.17%
5Y
+47.17%
Price Chart
ETF Exposure
IMVT is held by 98 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WSML | iShares MSCI World Small-Cap ETF | 0.02% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.01% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.01% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.01% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| V3AM.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About IMVT ETF Exposure
Immunovant, Inc. (IMVT) is held by 98 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.0B, IMVT is a widely held institutional stock. The stock currently trades at $24.39. Investors can gain exposure to IMVT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMVT, sorted by portfolio weight.